DNMT3A and prostate carcinoma: We assessed the effects of SFN and DIM on the expression of DNMT1, DNMT3A, and DNMT3B in normal prostate epithelial cells (PrEC), androgen-dependent (LnCAP) and androgen-independent (PC3) prostate cancer cells.